Name: UMIN ID:
Unique ID issued by UMIN | UMIN000005336 |
---|---|
Receipt number | R000006249 |
Scientific Title | A phase I/II study of S-1+Irinotecan+panitumumab as first line treatment to advanced colorectal cancer |
Date of disclosure of the study information | 2011/04/01 |
Last modified on | 2016/10/06 15:30:47 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2011/03/29 14:33:25 | ||
2 | Update | 2011/04/01 12:24:52 | Key inclusion criteria Key inclusion criteria Key exclusion criteria |
|
3 | Update | 2012/03/30 10:07:08 | Post marketing survey by drug manufacture etc., specified by Japanese law. Institutions |
|
4 | Update | 2012/03/30 10:08:27 | Recruitment status |
|
5 | Update | 2012/10/02 14:25:11 | Key inclusion criteria Key inclusion criteria Key exclusion criteria |
|
6 | Update | 2012/10/02 14:28:23 | Last name of lead principal investigator Name of person sending information Name of person sending information Organization Organization Address |
|
7 | Update | 2013/04/02 15:35:36 | Email |
|
8 | Update | 2013/09/30 14:13:42 | Email |
|
9 | Update | 2014/04/11 12:12:45 | Last follow-up date |
|
10 | Update | 2014/10/06 13:10:08 | Last follow-up date |
|
11 | Update | 2015/01/08 13:50:53 | Name of person sending information Name of person sending information |
|
12 | Update | 2015/01/08 13:51:31 | Recruitment status |
|
13 | Update | 2016/02/25 10:50:09 | Organization Organization Division name Division name Address Address TEL |
|
14 | Update | 2016/10/06 15:30:47 | Recruitment status Results Other related information |